Hanns Lochmüller is awarded prestigious Tier 1 Canada Research Chair in neuromuscular genomics and health

We are thrilled to announce that Hanns has been awarded a Canada Research Chair (CRC) in Neuromuscular Genomics and Health. The announcement was made at a ceremony at the University of Victoria at noon today. The prestigious Tier 1 CRC awards are for outstanding researchers acknowledged by their peers as world leaders in their fields. The program aims to help chairholders achieve research excellence, improve Canada’s depth of knowledge and quality of life, strengthen the country’s international competitiveness, and train the next generation of highly skilled researchers through student supervision, teaching, and research coordination. In the same announcement CHEO Professor Kym Boycott was awarded a Tier 1 CRC in Rare Disease Precision Health.

Hanns said: “This CRC award is part of what enabled my move from Europe to Canada, and together with our recently awarded CIHR Project grant allows us to establish a really exciting research program in neuromuscular genomics and health here at the CHEO Research Institute in close partnership with the Department of Medicine of The Ottawa Hospital and the Brain and Mind Research Institute of Ottawa University. I’m delighted that Kym Boycott, a long-term friend and collaborator, has also received a Tier 1 chair at the same time: this is a clear demonstration of the strategic importance of rare disease research here in Ottawa and our leadership role will benefit not only Canadian patients but also many others around the world.”

Hanns with research associate and lab manager Sally Spendiff

Find out more

CHEO Research Institute press release

Government of Canada press release

Canada Research Chair program details

Hanns-crc

Read next...

canada-nmd4c

New pan-Canadian neuromuscular network unites doctors, researchers and patients for better research and care

Network lead Dr Hanns Lochmüller In case you missed it! Exciting news for Canadian NMD networking. We're excited to share news...
Picture3

Good things come in 3s: New publications arising from EU funded collaborations on biomarker research and discovery

We are pleased to have been involved in this trio of papers examining biomarkers and genetic modifiers in Duchenne Muscular Dystrophy (DMD) and Becker Muscular...
arek-adeoye-ljoCgjs63SM-unsplash

Walk for Muscular Dystrophy Announce Dates and Times Across Canada

Muscular Dystrophy Canada (MDC) have announced the dates and times of their annual Walk for Muscular Dystrophy in more than 40 locations across Canada. Funds...
Picture2

New Publication: COL4A1-related autosomal recessive encephalopathy in 2 Turkish children

We are happy to have been involved with this paper presenting the neurological phenotypes of 2 Turkish brothers with a novel mutation. Through whole-exome sequencing...
Picture1

New Publication: Activities of daily living in myotonic dystrophy type 1

Our new paper on activities of daily living in patients with myotonic dystrophy type 1 (DM1) is now available online at Acta Neurologica Scandinavica. We...
Picture1

New publication: De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure

We were pleased to collaborate with colleagues  in Germany on this case report describing a de novo variant in SCN4A resulting in a phenotype of...